Augusta company creates first FDA approved brainwave test for ADHD

By  | 

News 12 First at Five/ Wednesday, Feb. 26, 2014


AUGUSTA, Ga. (WRDW) -- A local company is changing the face of ADHD testing. For years, clinical diagnosis has been the only option available to doctors, but a small research company out of Augusta has come up with a way to measure brain waves to help more accurately diagnose patients with ADHD.

It's a test Jill Sharpe is happy to hear about. She has a son that doctors have tried to test for ADHD.

"I had some teachers tell me maybe he should get tested for ADHD because they noticed he wasn't behaving like he should have," she said.

Since her son, John Thomas, was 6 years old, he's been in and out of doctors offices as doctors try to pinpoint his problem.

"We're still in the middle of testing, and he's in the sixth grade, so it's a long process," she explains.

They've looked at ADHD, Asperger Syndrome, Autism, along with a handful of other disorders, sampling different medications along the way.

"I don't want to drug my son up for something he really doesn't need. It might be something else because a lot of medications out there have stunted his growth. He has been on medications before where he was so little," she says.

That's why the new ADHD test, desinged by NEBA Health is giving her hope that they can finally either rule out ADHD as a problem, or accurately diagnose her son.

"I really would like to find out what's really his diagnosis. It's kinda like we're in the box and we just don't know. I really want to find out what is really wrong with my son," she said.

That's where NEBA will hopefully come into play, an extra layer of assessment on top of the tools doctors already use.

Howard Merry, the President of NEBA Health, says, "The doctor still uses all their standard tools and assessment protocols they just apply NEBA at the very end of it."

NEBA is intended to test kids 6-18 and is completely pain free. Merry says, "There's electrodes placed on the face and top of the head and the one on the top of the head is where we're really getting the EEG data we're interested in."

In clinical trials, using NEBA has helped doctors reduce over diagnosis of ADHD to around 3%.

The product was approved by the FDA this past year, and several healthcare providers have already started using it. For more information on finding a physician near you, go to